αv integrins: key regulators of tissue fibrosis

Overview of attention for article published in Cell and Tissue Research, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 3 X users

patent: 8 patents

Citations

dimensions_citation: 113 Dimensions

Readers on

mendeley: 142 Mendeley
citeulike: 1 CiteULike

Summary X Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders

Grant US-11485786-B2

United States of America

Integrin antagonists

Grant US-11306084-B2

United States of America

CHROMOGRANIN A-DERIVED PEPTIDES AND USES THEREOF

Application WO-2021094608-A1

World Intellectual Property Organisation (WIPO)

ANTI-INTEGRIN ANTIBODIES AND USES THEREOF

Application WO-2020210358-A1

World Intellectual Property Organisation (WIPO)

USE OF ALPHA-V-INTEGRIN (CD51) INHIBITORS FOR THE TREATMENT OF CARDIAC FIBROSIS

Application WO-2020074937-A1

World Intellectual Property Organisation (WIPO)

ALPHAvBETA1 INTEGRIN ANTAGONISTS

Application WO-2020009889-A1

World Intellectual Property Organisation (WIPO)

INTEGRIN ANTAGONISTS

Application WO-2018132268-A1

World Intellectual Property Organisation (WIPO)

ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF FIBROSIS AND/OR FIBROTIC DISORDERS

Application WO-2017088974-A3

World Intellectual Property Organisation (WIPO)